This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zuccarello, M. Articles by Anderson, D. K. Search for Related Content PubMed PubMed Citation Articles by Zuccarello, M. Articles by Anderson, D. K.

Stroke, Vol 20, 367-371, Copyright © 1989 by American Heart Association

ARTICLES

Protective effect of a 21-aminosteroid on the blood-brain barrier following subarachnoid hemorrhage in rats

M Zuccarello and DK Anderson
Veterans Administration Medical Center, Cincinnati, OH 45220.

The effects of subarachnoid injection of blood on blood-brain barrier permeability to albumin was assessed in a rat model. Subarachnoid injection of blood caused a significant sixfold increase in Evans blue extravasation, whereas sham operation or NaCl injection had no effect. In addition, subarachnoid injections of arachidonic acid or FeCl2 increased blood-brain barrier permeability to Evans blue 16- and 10- fold, respectively. The capillary permeability after subarachnoid injection of blood was normalized by pretreatment with a novel 21- aminosteroid, U-74006F, that has antioxidant and antilipolytic activity. Pretreatment with U-74006F also reduced the vascular leakage induced by subarachnoid injection of arachidonic acid or FeCl2 by 50% and 45%, respectively. We conclude that damage to membrane lipids by peroxidative and/or lipolytic processes is involved in the subarachnoid hemorrhage-induced blood-brain barrier opening and that U-74006F protects the blood-brain barrier against the effects of subarachnoid hemorrhage by preventing or limiting these pathologic membrane lipid changes.

This article has been cited by other articles:

				N. Lindenblatt, R. Bordel, W. Schareck, M.D. Menger, and B. Vollmar Vascular Heme Oxygenase-1 Induction Suppresses Microvascular Thrombus Formation In Vivo Arterioscler. Thromb. Vasc. Biol., March 1, 2004; 24(3): 601 - 606. [Abstract] [Full Text]

				R. J. Kavanagh and P. C. A. Kam Lazaroids: efficacy and mechanism of action of the 21-aminosteroids in neuroprotection Br. J. Anaesth., January 1, 2001; 86(1): 110 - 119. [Abstract] [Full Text] [PDF]

				B. S. Stonestreet, K. H. Petersson, G. B. Sadowska, K. D. Pettigrew, and C. S. Patlak Antenatal steroids decrease blood-brain barrier permeability in the ovine fetus Am J Physiol Regulatory Integrative Comp Physiol, February 1, 1999; 276(2): R283 - R289. [Abstract] [Full Text] [PDF]

				H. Suzuki, K. Kanamaru, M. Kuroki, H. Sun, S. Waga, T. Miyazawa, and R. L. Macdonald Effects of Tirilazad Mesylate on Vasospasm and Phospholipid Hydroperoxides in a Primate Model of Subarachnoid Hemorrhage • Editorial Comment Stroke, February 1, 1999; 30(2): 450 - 456. [Abstract] [Full Text] [PDF]

				C. Denis, N. Methia, P. S. Frenette, H. Rayburn, M. Ullman-Cullere, R. O. Hynes, and D. D. Wagner A mouse model of severe von Willebrand disease: Defects in hemostasis and thrombosis PNAS, August 4, 1998; 95(16): 9524 - 9529. [Abstract] [Full Text] [PDF]